Evidence-based Medicine Toolkit

More documents

Recommendations

Info

56 Evidence-based Medicine ToolkitRelative risk or risk ratio (RR)RR is the ratio of the risk in the experimental group divided by therisk in the control group.Absolute risk reduction (ARR)ARR is the difference between the event rates in the two groups.Relative risk reduction (RRR)Relative risk reduction is the ARR as a percentage of the controlgroup riskRRARRRRRMeaning 0 > 0 Less events in experimental group1 0 0 No difference between the groups>1 < 0 < 0 More events in experimental groupARR is a more clinically relevant measure to use than the RR orRRR. This is because relative measures ‘factor out’ the baselinerisk, so that small differences in risk can seem significant whencompared to a small baseline risk.Number needed to treat (NNT)Number needed to treat is the most useful measure of benefit, as ittells you the absolute number of patients who need to be treatedto prevent one bad outcome. It is the inverse of the ARR:NNT = 1/ARRThe confidence interval of an NNT is 1/the CI of its ARR:CER (1 – CER) + EER (1 – EER)95% CI on the ARR =√ n (control) n (experimental)
Appraising therapy articles 57Mortality in patients survivingacute myocardial infarctionfor at least 3 days with leftventricular ejection fraction
Page 1:
Evidence-basedMedicine ToolkitSECON
Page 5 and 6:
Evidence-basedMedicine ToolkitSECON
Page 7:
ContentsIntroduction, 1Asking answe
Page 10 and 11:
2 Evidence-based Medicine ToolkitTh
Page 12 and 13:
4 Evidence-based Medicine ToolkitPa
Page 14 and 15: 6 Evidence-based Medicine ToolkitTe
Page 16 and 17: 8 Evidence-based Medicine ToolkitCo
Page 18 and 19: 10 Evidence-based Medicine ToolkitG
Page 20 and 21: 12 Evidence-based Medicine ToolkitS
Page 22 and 23: 14 Evidence-based Medicine Toolkit3
Page 28 and 29: 20 Evidence-based Medicine ToolkitF
Page 34 and 35: 26 Evidence-based Medicine Toolkitm
Page 36 and 37: 28 Evidence-based Medicine ToolkitI
Page 38 and 39: 30 Evidence-based Medicine Toolkit
Page 40 and 41: 32 Evidence-based Medicine ToolkitO
Page 42 and 43: Appraising diagnosis articlesIs the
Page 44 and 45: 36 Evidence-based Medicine ToolkitT
Page 48 and 49: 40 Evidence-based Medicine ToolkitP
Page 50 and 51: Appraising articles on harm/aetiolo
Page 54 and 55: Appraising prognosis studiesIs the
Page 56 and 57: 48 Evidence-based Medicine Toolkiti
Page 58 and 59: Appraising therapy articlesIs the s
Page 66 and 67: 58 Evidence-based Medicine Toolkita
Page 68 and 69: 60 Evidence-based Medicine ToolkitE
Page 70 and 71: 62 Evidence-based Medicine Toolkitb
Page 72 and 73: 64 Evidence-based Medicine Toolkita
Page 74 and 75: 66 Evidence-based Medicine ToolkitE
Page 80 and 81: 72 Evidence-based Medicine ToolkitA
Page 87 and 88: Evidence-based medicine:glossary of
Page 89 and 90: Evidence-based medicine: glossary o
Page 95 and 96: Selected evidence-based healthcare
Page 103 and 104: LevelRx/prevention,aetiology/harmPr
Page 105 and 106: Study designsThis page gives a brie
Page 107: Study designs 99expensive, sometime
Page 110 and 111: 102 Indexcrossover design 98cross-s
Page 112 and 113: 104 Indexpatient(s)extent of study
show all

Evidence-based Medicine Toolkit

Create successful ePaper yourself

Delete template?

Save as template?